Gopro Inc (GPRO) 25.00 $GPRO 2 Hires That Will Help

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gopro Inc (GPRO) 25.00 $GPRO

2 Hires That Will Help Transform GoPro Inc.
James Sullivan, The Motley Fool - Motley Fool - Sun Nov 01, 11:31AM CST
Hero+ Camera Source: GoPro. GoPro has been transitioning from being a pure hardware company to one focused on original content production and distribution. In February the GoPro app, which shows user-generated footage taken on GoPro cameras,...
GPRO: 25.00 (-0.62)

Drone Regulations Are On the Way
Travis Hoium, The Motley Fool - Motley Fool - Sat Oct 31, 8:42AM CDT
Image source: Aerovironment. Drone regulations are starting to come out from regulatory agencies tasked with keeping the skies safe, and that could be good or bad for drone makers, depending on how you look at it. The Federal Aviation...
GPRO: 25.00 (-0.62), AVAV: 23.07 (+0.17)

Gen-Probe Down 55.3% Since SmarTrend Downtrend Call (GPRO)
Comtex SmarTrend(R) - Fri Oct 30, 4:52PM CDT
SmarTrend identified a Downtrend for Gen-Probe (AMEX:GPRO) on August 12th, 2015 at $55.89. In approximately 3 months, Gen-Probe has returned 55.27% as of today's recent price of $25.00.
GPRO: 25.00 (-0.62)

Jim Cramer -- Buy Panera, WhiteWave, Target Now; Don't Fall for GoPro
at The Street - Fri Oct 30, 2:39PM CDT
TheStreet's Jim Cramer, Action Alerts Plus Portfolio Manager and host of CNBC's 'Mad Money,' talked about Exxon and Chevron Friday from the floor of the New York Stock Exchange.
WFM: 29.96 (-0.19), AMZN: 625.90 (-0.65), GPRO: 25.00 (-0.62), PNRA: 177.37 (-2.32), FB: 101.97 (-2.91), BBW: 15.56 (+1.31), WMT: 57.24 (-0.72), XOM: 82.74 (+0.51), HRL: 67.55 (-0.28), WWAV: 40.98 (+0.74), HAIN: 49.85 (-0.22), TGT: 77.18 (+0.90), COST: 158.12 (-0.16), TWTR: 28.46 (-0.60), CVX: 90.88 (+0.99), GIS: 58.11 (-0.07)

Apple and the Law of Large Numbers
at The Street - Fri Oct 30, 2:00PM CDT
And does anybody think a Walgreens-Rite Aid deal is a good idea?
GPRO: 25.00 (-0.62), WBA: 84.68 (+0.80), TWTR: 28.46 (-0.60), AAPL: 119.50 (-1.03), GG: 12.82 (-0.32), RAD: 7.88 (unch)

Is GoPro Inc's $300 Million Buyback an "Unheroic" Move?
Leo Sun, The Motley Fool - Motley Fool - Fri Oct 30, 12:00PM CDT
GoPro (NASDAQ: GPRO) recently reported weak third-quarter earnings that missed both top- and bottom-line estimates, marking its first miss since going public last July. Guidance for the current holiday quarter also came in ...
GPRO: 25.00 (-0.62), GOOGL: 737.39 (-7.46), GOOG: 710.81 (-6.11)

Why Ambarella Inc Stock Dropped 10.8% Thursday
Steve Symington, The Motley Fool - Motley Fool - Fri Oct 30, 9:41AM CDT
What: Shares of video chip specialist Ambarella Inc   fell 10.8% Thursday after GoPro announced weaker-than-expected third-quarter results and light forward guidance. So what: Ambarella is GoPro's primary video chip supplier, so it's not...
AMBA: 49.44 (-0.94), GPRO: 25.00 (-0.62)

'Fast Money' Recap: Investors Remain Focused on Earnings
at The Street - Fri Oct 30, 4:00AM CDT
The trading panel discussed Starbucks' earnings results Thursday, as well as other companies including LinkedIn.
SBUX: 62.57 (+0.07), MU: 16.56 (+0.35), GPRO: 25.00 (-0.62), LNKD: 240.87 (+23.87), TXN: 56.72 (+0.15), NXPI: 78.35 (+5.35), INTC: 33.86 (-0.17), NVDA: 28.37 (+0.69)

Here’s Why GoPro and NXP Plunged Today -- Tech Roundup
at The Street - Thu Oct 29, 3:39PM CDT
GoPro shares declined by more than 15%, while NXP Semiconductors plunged by nearly 20%.
AMBA: 49.44 (-0.94), GPRO: 25.00 (-0.62), FFIV: 110.20 (+0.12), SNE: 28.40 (+0.30), NXPI: 78.35 (+5.35), YELP: 22.25 (-0.70), FSL: 33.49 (+1.80), AAPL: 119.50 (-1.03)

GoPro, F5 Networks Downgraded; SunPower PT Cut
at Investor's Business Daily - Thu Oct 29, 3:38PM CDT
GoPro (GPRO) and F5 Networks (FFIV) shares sank after analyst downgrades that followed weak quarterly results, while SunPower (SPWR) got its price target cut. Piper Jaffray downgraded GoPro to underweight from neutral and lowered its price target to...
GPRO: 25.00 (-0.62), NOC: 187.75 (-2.32), FFIV: 110.20 (+0.12), SPWR: 26.84 (-0.52), BWLD: 154.27 (+1.82)

GoPro, Chip Stocks Sink Nasdaq; Starbucks Dips Ahead Of Earnings
at Investor's Business Daily - Thu Oct 29, 3:17PM CDT
Stocks closed in the red Thursday after spending most of the session underwater amid disappointing economic data. The S&P 500 finished fractionally lower after flirting with positive territory; the Dow Jones industrial average gave up 0.1% and the...
GPRO: 25.00 (-0.62), ELLI: 72.98 (-2.62), ORLY: 276.26 (+0.31), IDTI: 25.50 (+1.17), NXPI: 78.35 (+5.35), SBUX: 62.57 (+0.07), BIDU: 187.47 (+18.48), LNKD: 240.87 (+23.87), MTSI: 33.74 (+0.66), AVGO: 123.13 (+3.04)

The Prevailing Question: What Went Wrong?
at The Street - Thu Oct 29, 2:10PM CDT
The market perils of guilt by association.
F: 14.81 (+0.08), PNRA: 177.37 (-2.32), BWLD: 154.27 (+1.82), INTC: 33.86 (-0.17), DLPH: 83.19 (+3.15), SWK: 105.98 (-0.48), CMG: 640.23 (-7.97), DPZ: 106.67 (-2.73), GOOGL: 737.39 (-7.46), AAPL: 119.50 (-1.03), AMBA: 49.44 (-0.94), AMZN: 625.90 (-0.65), GPRO: 25.00 (-0.62), HD: 123.64 (+0.01), SWKS: 77.24 (+2.61), FBHS: 52.33 (+0.31), FB: 101.97 (-2.91), NXPI: 78.35 (+5.35), MAS: 29.00 (+0.32), DIN: 83.45 (-1.40), LEA: 125.06 (+1.42), DRI: 61.89 (-0.54), NFLX: 108.38 (+3.26), BWA: 42.82 (+1.25), TXN: 56.72 (+0.15), MCD: 112.25 (-0.37), GM: 34.91 (+0.16), SHW: 266.83 (+8.72), AVGO: 123.13 (+3.04), CRM: 77.71 (-0.43)

Stocks Are Slightly Lower; Oil Tops $46
at The Street - Thu Oct 29, 1:55PM CDT
Stocks are slightly lower by mid-afternoon Thursday with the energy sector struggling to stay positive as crude oil tops $46 a barrel.
PSX: 89.05 (+2.62), GPRO: 25.00 (-0.62), PBR.A: 3.99 (+0.06), WBK: 22.37 (-0.16), C: 53.17 (-0.49), PFE: 33.82 (-0.95), AMGN: 158.18 (-2.40), DB: 27.95 (+0.06), PYPL: 36.01 (+0.10), WFC: 54.14 (-0.95), BAC: 16.78 (-0.31), MGM: 23.19 (+0.39), AGN: 308.47 (+4.09), JPM: 64.25 (-0.96), BP: 35.70 (-0.01), TWC: 189.40 (-2.42), SNY: 50.34 (+0.71), YELP: 22.25 (-0.70), XLF: 24.08 (-0.35), MA: 98.99 (-1.60), XLE: 68.03 (+0.44)

Is GoPro Finally a Buy After Collapsing This Year?
at The Street - Thu Oct 29, 1:27PM CDT
The CNBC 'Fast Money' traders debate whether now is the time buy shares of GoPro, which are down more than 60% on the year.
GPRO: 25.00 (-0.62), GNC: 29.75 (+1.51), NXPI: 78.35 (+5.35), BWLD: 154.27 (+1.82)

Jim Cramer -- Allergan May Get a Higher Bid from Pfizer; Biotech to Buy
at The Street - Thu Oct 29, 1:25PM CDT
From the floor of the New York Stock Exchange, TheStreet's Jim Cramer takes viewer questions posted on Twitter. He looks at Allergan, Pfizer and other stocks.
BIIB: 290.51 (-3.21), GPRO: 25.00 (-0.62), SWKS: 77.24 (+2.61), FB: 101.97 (-2.91), AVT: 45.43 (+0.62), PFE: 33.82 (-0.95), VFC: 67.52 (-0.59), M: 50.98 (+1.28), AMGN: 158.18 (-2.40), LLY: 81.57 (-0.43), BMY: 65.95 (-1.36), NXPI: 78.35 (+5.35), INTC: 33.86 (-0.17), CELG: 122.71 (-2.22), AGN: 308.47 (+4.09), RDUS: 64.23 (+1.19), WBA: 84.68 (+0.80), QRVO: 43.93 (+0.12), TXN: 56.72 (+0.15), TGT: 77.18 (+0.90), ADI: 60.12 (+0.14), TWTR: 28.46 (-0.60), AAPL: 119.50 (-1.03), AVGO: 123.13 (+3.04)

GoPro Goes Blurry in a Difficult Quarter
Steve Symington, The Motley Fool - Motley Fool - Thu Oct 29, 1:13PM CDT
GoPro CEO Nick Woodman admits initial sell-through of the HERO4 Session was "weak." Image source: GoPro. GoPro   just announced a rough quarter, and the market is responding in kind. After climbing 7% in Wednesday's regular trading leading up to...
GPRO: 25.00 (-0.62)

GoPro Could Be an 'Exceptionally Attractive' Buy -- What Wall Street's Saying
at The Street - Thu Oct 29, 11:51AM CDT
GoPro is eliciting cautious optimism after a pain third quarter.
GPRO: 25.00 (-0.62)

Why GoPro, Inc. Stock Tumbled Today
Steve Symington, The Motley Fool - Motley Fool - Thu Oct 29, 11:12AM CDT
What:  Shares of GoPro fell more than 16% early Thursday after the action camera maker announced weaker-than-expected third-quarter results and light forward guidance. So what: Quarterly revenue rose 43% year over year to $400.3 million,...
GPRO: 25.00 (-0.62)

Stocks Slip as Deutsche Bank Leads Financials Lower
at The Street - Thu Oct 29, 10:35AM CDT
Stocks retreat on Thursday after third-quarter U.S. GDP slows and as Deutsche Bank leads the financial sector lower.
GPRO: 25.00 (-0.62), WBK: 22.37 (-0.16), C: 53.17 (-0.49), PFE: 33.82 (-0.95), DB: 27.95 (+0.06), AMGN: 158.18 (-2.40), COP: 53.35 (-0.27), BAC: 16.78 (-0.31), WFC: 54.14 (-0.95), PYPL: 36.01 (+0.10), BWLD: 154.27 (+1.82), MGM: 23.19 (+0.39), AGN: 308.47 (+4.09), JPM: 64.25 (-0.96), TWC: 189.40 (-2.42), XLF: 24.08 (-0.35), YELP: 22.25 (-0.70), SNY: 50.34 (+0.71), MA: 98.99 (-1.60)

Why GoPro (GPRO) Stock Is Sinking Today
at The Street - Thu Oct 29, 8:49AM CDT
GoPro (GPRO) shares are lower after the company missed analysts' estimates for earnings and revenue in the third quarter, and issued a light guidance for the fourth quarter.
GPRO: 25.00 (-0.62)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 269

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 127

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 59

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
NOTHING NINE's Global Ambitions: Paris Show's Impact

Updated Category News Views 83

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Continue Reading
Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Updated Category News Views 13

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Continue Reading
Superteam Wheels Rides Into Spain with RACEIT Deal

Updated Category News Views 63

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 98

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 81

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
ASICS and University of Michigan Launch Innovation Lab

Updated Category News Views 88

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 412

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

TuHURA Biosciences Advances Phase 3 Trial for Cancer Treatment

Updated Category News Views 229

TuHURA Biosciences Moves Forward with Phase 3 Trial TuHURA Biosciences, Inc. (NASDAQ: HURA) is making substantial strides in the field of cancer immunotherapy. The company is geared up to launch its Phase 3 accelerated approval trial of IFx-2.0, a promising adjunctive therapy in combination with Keytruda (pembrolizumab), targeting advanced and metastatic Merkel cell...

Continue Reading
Fiserv, Inc. Lawsuit: Investors Can Fight Back Against Losses

Updated Category News Views 198

Introduction to the Class Action Lawsuit In recent news, numerous investors in Fiserv, Inc. are being alerted to an important opportunity. A class action lawsuit has been initiated targeting Fiserv, a prominent figure in the financial services tech sector. This situation arises from allegations of significant financial losses endured by shareholders due to the Company's...

Continue Reading
Exploring Humana's Decreased Short Interest and Market Impact

Updated Category News Views 104

Understanding Humana's Short Interest Trends Recently, Humana Inc (NYSE: HUM) has reported a notable decline in its short percent of float, decreasing by 6.3% since the previous report. As of now, the company has approximately 4.30 million shares sold short, which constitutes about 3.57% of the total shares available for trading. Based on the current trading volumes, it...

Continue Reading
Innovative Restaurant Launch Featuring AI Robots Opens Soon

Updated Category News Views 344

AI-Driven Restaurant Opening at Walmart Supercenter In an exciting development for the dining industry, Richtech Robotics Inc. (NASDAQ: RR), a leader in AI-driven service robots, has joined forces with Ghost Kitchens America to unveil their latest One Kitchen restaurant. This location, situated within a Walmart Supercenter, is marking a significant milestone as it becomes...

Continue Reading
Choosing the Perfect MySmile Teeth Whitening Solution for You

Updated Category News Views 82

Your Guide to MySmile Teeth Whitening Products Achieving a whiter, brighter smile is easier than ever with MySmile's effective teeth whitening solutions. MySmile offers a range of products tailored to fit different lifestyles; whether you're interested in an all-in-one kit, convenient whitening strips, or one-step solutions, the right product is just a choice away. Let's...

Continue Reading